2026
This S, Desjardins-Lecavalier N, Melichar HJ*, Costantino S*. (2026) ART-CLaP: antigen-reactive T cell isolation based on intracellular calcium dynamics. The Journal of Immunology (in review).
This S, Playout C, Lacroix S, Valbon SD, Hayer A, Costantino S*, Melichar HJ*. (2026) Intracellular calcium dynamics are predictive of T cell receptor affinity for cognate antigen. Science Advances (submitted).
This S*, Brichart-Vernos D*, Väänänen VA, Rey C, Barateau V, Fenouil T, Mörbe UM, Daniel L, Nishimura SL, Graff-Dubois S, Thaunat O, Agace WW, Paidassi H. (2026) Type 1 and type 2 dendritic cell subsets cooperate to maintain intestinal immune tolerance via integrin αvβ8-mediated TGF-β activation. Immunity (in review)
Other selected publications
This S*, Rogers D*, Mallet-Gauthier È, Mandl JN, Melichar HJ. (2023) What’s self got to dowith it: Sources of heterogeneity among naive T cells. Seminars in Immunology
This S, & Paidassi H. (2022) New perspectives on the regulation of germinal center reaction via αvβ8-mediated activation of TGFβ. Frontiers in Immunology
This S*, Valbon SF*, Lebel M-È, & Melichar HJ (2021) Strength and numbers: The role of affinity and avidity in the “quality”of T cell tolerance. Cells
Nakawesi J*,This S*, Hütter J, Boucard-Jourdin M, Barateau V, Muleta KG, Gooday LJ,Thomsen KF, López AG, Ulmert I, Poncet D, Malissen B, Greenberg H, Thaunat O, Defrance T, Paidassi H, Lahl K. (2021) αvβ8 integrin-expression by BATF3-dependent dendritic cells facilitates early IgA responses to Rotavirus. Mucosal Immunology
2024
This S, Costantino S, Melichar HJ. (2024) Machine learning predictions of T cell antigen specificity from intracellular calcium dynamics. Science Advances
2025
Barba T, Oberbarnscheidt M, Franck G, Gao C, This S, Rabeyrin M, Roufosse C, Moran L, Koenig A, Mathias V, Saison C, Dubois V, Pallet N, Anglicheau D, Lamarthée B, Hertig A, Morelon E, Hot A, Paidassi H, Defrance T, Nicoletti A, Duong-Van-Huyen JP, Xu-Dubois Y, Lakkis FG, Thaunat O. (2025) Chemotaxis overrides killing response in alloreactive cytotoxic T-cells providing vascular immune privilege during cellular rejection. The Journal of Clinical Investigation
* Equal contribution